Date: 4/02/2019 18:05:55
From: ChrispenEvan
ID: 1340724
Subject: Vaccine for Streptococcus pneumoniae

https://www.adelaide.edu.au/news/news104682.html

A vaccine against the biggest bacterial killer on the planet is a step closer to being available with funding secured for preclinical trials.

Professor James Paton, Director of the University of Adelaide’s Research Centre for Infectious Diseases and his team have been working on a vaccine for Streptococcus pneumoniae (the pneumococcus) that could save two million lives globally a year and address the overuse of antibiotics that leads to resistance.

“The pneumococcus is the biggest bacterial killer on the planet. It’s the most common cause of pneumonia, which is responsible for about 20 per cent of deaths from all causes in children under 5 years in developing countries. Globally, the pneumococcus accounts for about two million deaths a year,” says Professor Paton.

more

Reply Quote

Date: 6/02/2019 11:04:44
From: mollwollfumble
ID: 1341569
Subject: re: Vaccine for Streptococcus pneumoniae

ChrispenEvan said:


https://www.adelaide.edu.au/news/news104682.html

A vaccine against the biggest bacterial killer on the planet is a step closer to being available with funding secured for preclinical trials.

Professor James Paton, Director of the University of Adelaide’s Research Centre for Infectious Diseases and his team have been working on a vaccine for Streptococcus pneumoniae (the pneumococcus) that could save two million lives globally a year and address the overuse of antibiotics that leads to resistance.

“The pneumococcus is the biggest bacterial killer on the planet. It’s the most common cause of pneumonia, which is responsible for about 20 per cent of deaths from all causes in children under 5 years in developing countries. Globally, the pneumococcus accounts for about two million deaths a year,” says Professor Paton.

more

“The problem with the existing pneumococcal vaccine is that it targets the outside coat of complex carbohydrates – of which there are 98 structurally distinct types. The current vaccine costs about $150 a dose and only covers 13 types.”

“What we have done is to remove this coat to expose all the surface proteins that are common to all pneumococcal types. The body mounts an immune response to these surface proteins.”

That helps to clarify the problem.

Reply Quote

Date: 6/02/2019 11:09:04
From: poikilotherm
ID: 1341572
Subject: re: Vaccine for Streptococcus pneumoniae

mollwollfumble said:


ChrispenEvan said:

https://www.adelaide.edu.au/news/news104682.html

A vaccine against the biggest bacterial killer on the planet is a step closer to being available with funding secured for preclinical trials.

Professor James Paton, Director of the University of Adelaide’s Research Centre for Infectious Diseases and his team have been working on a vaccine for Streptococcus pneumoniae (the pneumococcus) that could save two million lives globally a year and address the overuse of antibiotics that leads to resistance.

“The pneumococcus is the biggest bacterial killer on the planet. It’s the most common cause of pneumonia, which is responsible for about 20 per cent of deaths from all causes in children under 5 years in developing countries. Globally, the pneumococcus accounts for about two million deaths a year,” says Professor Paton.

more

“The problem with the existing pneumococcal vaccine is that it targets the outside coat of complex carbohydrates – of which there are 98 structurally distinct types. The current vaccine costs about $150 a dose and only covers 13 types.”

“What we have done is to remove this coat to expose all the surface proteins that are common to all pneumococcal types. The body mounts an immune response to these surface proteins.”

That helps to clarify the problem.

FMD, $150 … it’s ~$40-50 and covers 23 types.

Reply Quote